• Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19

      Luo, H; Wang, Y; Liu, S; Chen, R; Chen, T; Yang, Y; Wang, D; Ju, S; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK. (Springer, 2021-06-30)
      This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in COVID-19 patients. The retrospective multi-center cohort study included 496 COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: ≤ 5%, 6–20%, 21–40% and 41% +. CT pulmonary opacity score was independently associated with age, single onset, fever, cough, peripheral capillary oxygen saturation, lymphocyte count, platelet count, albumin level, C-reactive protein (CRP) level and fibrinogen level on admission. Patients with score ≥ 41% had a dramatic increased risk of severe or critical illness [odds ratio (OR), 15.58, 95% confidence interval (CI) 3.82–63.53), intensive care unit (ICU)] admission (OR, 6.26, 95% CI 2.15–18.23), respiratory failure (OR, 19.49, 95% CI 4.55–83.40), and a prolonged hospital stay (coefficient, 2.59, 95% CI 0.46–4.72) compared to those with score ≤ 5%. CT pulmonary opacity score on admission, especially when ≥ 41%, was closely related to some clinical characteristics and was an independent predictor of disease severity, ICU admission, respiratory failure and long hospital stay in patients with COVID-19.